CTUY Stock | News | Quote | Stock Forum | Monday, October 7,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Century Next Financial Corp CTUY Company Overview 

Stock Message Board http://investorshangout.com/search?q=CTUY&...mp;yt1=Go!

Last Updated: Monday, October 7, 2013 12:19:16 PM

Century Next Financial Corp CTUY Current Price and Quotes
Last Price 17.15
Previous Close 17.15 Open 17.15
Daily Range 17.15 - 17.15 52wk Range 17.60 - 12.40
Volume 100 Dividend N/A
Average Vol (3m) 1,023 Yield N/A
Century Next Financial Corp CTUY
Company Information

505 North Vienna St.
Ruston, LA 71270

Website: https://www.bankruston.com
Phone: 318-255-3733

Century Next Financial Corp CTUY
Not Available

Century Next Financial Corp CTUY
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: Bank/Thrift
Deregistered a/o Oct 04, 2013
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
Regulatory Agency Federal Deposit Insurance Corporation
CIK 0001493006
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 6035 - Federal savings institutions
Incorporated In: LA, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Benjamin L. Denny President, CEO
Mark A. Taylor CFO
Mark A. Taylor Senior VP, CFO
Company Directors

Not Available
Service Providers

Auditor/Accountant
Heard, McElroy & Vestal, LLP
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Century Next Financial Corp CTUY
CTUY Security Details

Share Structure

Market Value1 $18,065,964 a/o Oct 07, 2013
Shares Outstanding 1,053,409 a/o Aug 09, 2013
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record 205 a/o Mar 26, 2013
Short Selling Data

Short Interest 0 (-100%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Registrar and Transfer Co.

Century Next Financial Corp CTUY Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue 6,580 6,124
Cost of Revenue 632 776
Gross Profit - -
Operating Expenses

Research and Development - -
Sales, General and Admin. 4,745 4,237
Non-Recurring Items 101 190
Other 120 56
Operating Income - -
Income From Continuing Operations

Add'l Income/Expense Items - -
Earnings Before Interest and Tax 982 865
Interest Expense 25 25
Earnings Before Tax 957 840
Income Tax 301 206
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations 656 634
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 656 634
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 656 634

Century Next Financial Corp CTUY Recent News

Oct 3, 2013 Century Next Financial Corporation to Deregister Its Common Stock


CTUY Century Next Financial Corp Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CTUY&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CTUY/quote
Stock Chart http://www.otcmarkets.com/stock/CTUY/chart
Company Info http://www.otcmarkets.com/stock/CTUY/company-info
Recent News http://www.otcmarkets.com/stock/CTUY/news
Financials http://www.otcmarkets.com/stock/CTUY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CTUY/filings
Short Sales http://www.otcmarkets.com/stock/CTUY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CTUY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CTUY/research
Summary http://finance.yahoo.com/q?s=CTUY
Historical Prices http://finance.yahoo.com/q/hp?s=CTUY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CTUY
Basic Chart http://finance.yahoo.com/q/bc?s=CTUY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTUY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CTUY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CTUY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CTUY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CTUY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CTUY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CTUY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CTUY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CTUY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CTUY
Balance Sheet http://finance.yahoo.com/q/bs?s=CTUY
Cash Flow http://finance.yahoo.com/q/cf?s=CTUY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CTUY
Market Watch http://www.marketwatch.com/investing/stock/CTUY
Bloomberg http://www.bloomberg.com/quote/CTUY:US
Morningstar http://quotes.morningstar.com/stock/s?t=CTUY
Bussinessweek http://investing.businessweek.com/research/st...icker=CTUY
Barchart http://www.barchart.com/quotes/stocks/CTUY
OTC Short Report http://otcshortreport.com/index.php?index=CTUY
Investopedia http://www.investopedia.com/markets/stocks/CTUY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Market News: Nasdaq Dips as Applied Materials Shines

Updated Category News Views 191

Stock Market Declines on Nasdaq Today, U.S. stocks faced challenges with the Nasdaq Composite dropping significantly. The market opened lower with declines across major indices, signaling a cautious trading atmosphere. Market Overview As the day progressed, the Dow Jones Industrial Average fell by 1.21% to 46,882.86, while the NASDAQ retreated by 1.51%, settling at...

Continue Reading
Fastly Eyewitness: A Look at Recent Stock Performance

Updated Category News Views 205

Fastly's Impressive Stock Surge Fastly stock has recently shown remarkable movement, trading at near recent highs, indicating strong investor confidence in the company. The notable increase has left many wondering how long this momentum can be sustained. AI Transformation Sparks Interest Shifting Perspectives in Technology The recent ascent of Fastly's stock is largely...

Continue Reading
Exploring the Transformation of Social Media Management Market

Updated Category News Views 139

Understanding the Evolution of the Social Media Management Market The social media management market is experiencing remarkable growth. From a value of $17.5 billion in 2022, projections indicate it may reach $51.8 billion by 2027. This surge represents a compound annual growth rate (CAGR) of 24.2%. Companies worldwide are adapting to the increasing reliance on social...

Continue Reading
WestBond Enterprises Posts Year-End Financial Results and Outlook

Updated Category News Views 166

WestBond Enterprises Financial Overview WestBond Enterprises Corporation (TSX-V: WBE), a notable player in the manufacturing sector, has reported a financial loss of $52,380 for the year ending in March, reflecting a notable decrease from the previous year's loss of $210,683. Despite the loss, the company experienced a 4.9% increase in sales, which totaled $9,673,002,...

Continue Reading
Investors of Ultra Clean Urged to Act Amidst Stock Decline

Updated Category News Views 239

Investigation by Faruqi & Faruqi for Ultra Clean Investors Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors who have experienced losses exceeding $50,000 in Ultra Clean Holdings, Inc. (NASDAQ: UCTT). The firm aims to discuss potential legal options available to these investors following troubling financial disclosures from Ultra...

Continue Reading